Please use this identifier to cite or link to this item: http://ir.mu.ac.ke:8080/jspui/handle/123456789/154
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPaula, Braitstein-
dc.contributor.authorSiika, Abraham-
dc.contributor.authorHogan, Joseph-
dc.contributor.authorKosgei, Rose-
dc.contributor.authorSang, Edwin-
dc.contributor.authorSidle, John-
dc.contributor.authorWools-Kaloustian, Kara-
dc.contributor.authorKeter, Alfred-
dc.contributor.authorMamlin, Joseph-
dc.contributor.authorKimaiyo, Sylvester-
dc.date.accessioned2017-10-04T13:17:24Z-
dc.date.available2017-10-04T13:17:24Z-
dc.date.issued2012-02-
dc.identifier.urihttps://www.biomedcentral.com/1758-2652/content/15/1/7-
dc.identifier.urihttp://ir.mu.ac.ke:8080/xmlui/handle/123456789/154-
dc.description.abstractBackground: In resource-poor settings, mortality is at its highest during the first 3 months after combination antiretroviral treatment (cART) initiation. A clear predictor of mortality during this period is having a low CD4 count at the time of treatment initiation. The objective of this study was to evaluate the effect on survival and clinic retention of a nurse-based rapid assessment clinic for high-risk individuals initiating cART in a resource-constrained setting. Methods: The USAID-AMPATH Partnership has enrolled more than 140,000 patients at 25 clinics throughout western Kenya. High Risk Express Care (HREC) provides weekly or bi-weekly rapid contacts with nurses for individuals initiating cART with CD4 counts of ≤100 cells/mm3. All HIV-infected individuals aged 14 years or older initiating cART with CD4 counts of ≤100 cells/mm3 were eligible for enrolment into HREC and for analysis. Adjusted hazard ratios (AHRs) control for potential confounding using propensity score methods. Results: Between March 2007 and March 2009, 4,958 patients initiated cART with CD4 counts of ≤100 cells/mm3. After adjusting for age, sex, CD4 count, use of cotrimoxazole, treatment for tuberculosis, travel time to clinic and type of clinic, individuals in HREC had reduced mortality (AHR: 0.59; 95% confidence interval: 0.45-0.77), and reduced loss to follow up (AHR: 0.62; 95% CI: 0.55-0.70) compared with individuals in routine care. Overall, patients in HREC were much more likely to be alive and in care after a median of nearly 11 months of follow up (AHR: 0.62; 95% CI: 0.57-0.67). Conclusions: Frequent monitoring by dedicated nurses in the early months of cART can significantly reduce mortality and loss to follow up among high-risk patients initiating treatment in resource-constrained settings.en_US
dc.description.sponsorshipThe USAID-AMPATH Rockefeller Foundation Kenyan National Leprosy,Tuberculosis, and Lung Disease (NLTLD) Programmeen_US
dc.language.isoenen_US
dc.publisherJournal of the International AIDS Societyen_US
dc.subjectAntiretroviralsen_US
dc.subjectMortalityen_US
dc.subjectLosses to follow upen_US
dc.subjectAdherenceen_US
dc.subjectModels of careen_US
dc.subjectAfricaen_US
dc.titleA clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatmenten_US
dc.typeArticleen_US
Appears in Collections:School of Medicine

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.